3 Things In Biotech, March 23: Booking 3 Pieces Of Bad News


Welcome to another edition of "3 Things In Biotech," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research. News: PGNX announced that the FDA has delayed the PDUFA date for its lead agent Azedra by three months, placing the action date on July 30. This was due to additional CMC information that the company needed to produce, which will take additional time to review.



from Biotech News